MAPT and Alzheimer disease: Epigenetic modifications play a crucial role in AD pathology and cognitive function through their involvement in processes such as APP metabolism, Aβ formation, tau phosphorylation, oxidative stress responses, apoptosis, and inflammatory responses [24].